Science 28 April 1995: Vol. 268. no. 5210, pp. 567 - 569 DOI: 10.1126/science.7536959

Prev | Table of Contents | Next

Articles

EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

M. A. Cercone, W. Schroeder, S. Schomberg, and T. C. Carpenter (2009)
Am J Physiol Lung Cell Mol Physiol 297, L856-L863
 |  Abstract »  |  Full Text »  |  PDF »

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors.

G. D. Demetri, P. Lo Russo, I. R.J. MacPherson, D. Wang, J. A. Morgan, V. G. Brunton, P. Paliwal, S. Agrawal, M. Voi, and T.R. J. Evans (2009)
Clin. Cancer Res. 15, 6232-6240
 |  Abstract »  |  Full Text »  |  PDF »

EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma.

J.-W. Lee, H. D. Han, M. M. K. Shahzad, S. W. Kim, L. S. Mangala, A. M. Nick, C. Lu, R. R. Langley, R. Schmandt, H.-S. Kim, et al. (2009)
J Natl Cancer Inst 101, 1193-1205
 |  Abstract »  |  Full Text »  |  PDF »

Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis.

B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs (2009)
Mol. Cancer Res. 7, 1021-1032
 |  Abstract »  |  Full Text »  |  PDF »

The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting.

J. Wykosky and W. Debinski (2008)
Mol. Cancer Res. 6, 1795-1806
 |  Abstract »  |  Full Text »  |  PDF »

A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo.

D. Jackson, J. Gooya, S. Mao, K. Kinneer, L. Xu, M. Camara, C. Fazenbaker, R. Fleming, S. Swamynathan, D. Meyer, et al. (2008)
Cancer Res. 68, 9367-9374
 |  Abstract »  |  Full Text »  |  PDF »

Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors.

R. Noberini, M. Koolpe, S. Peddibhotla, R. Dahl, Y. Su, N. D. P. Cosford, G. P. Roth, and E. B. Pasquale (2008)
J. Biol. Chem. 283, 29461-29472
 |  Abstract »  |  Full Text »  |  PDF »

Endothelial EphA receptor stimulation increases lung vascular permeability.

J. Larson, S. Schomberg, W. Schroeder, and T. C. Carpenter (2008)
Am J Physiol Lung Cell Mol Physiol 295, L431-L439
 |  Abstract »  |  Full Text »  |  PDF »

Hypoxia-inducible Transcription Factor-2{alpha} in Endothelial Cells Regulates Tumor Neovascularization through Activation of Ephrin A1.

T. Yamashita, K. Ohneda, M. Nagano, C. Miyoshi, N. Kaneko, Y. Miwa, M. Yamamoto, O. Ohneda, and Y. Fujii-Kuriyama (2008)
J. Biol. Chem. 283, 18926-18936
 |  Abstract »  |  Full Text »  |  PDF »

Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase.

W. B. Fang, D. M. Brantley-Sieders, Y. Hwang, A.-J. L. Ham, and J. Chen (2008)
J. Biol. Chem. 283, 16017-16026
 |  Abstract »  |  Full Text »  |  PDF »

MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3.

P. Fasanaro, Y. D'Alessandra, V. Di Stefano, R. Melchionna, S. Romani, G. Pompilio, M. C. Capogrossi, and F. Martelli (2008)
J. Biol. Chem. 283, 15878-15883
 |  Abstract »  |  Full Text »  |  PDF »

Fibronectin Type I Repeat Is a Nonactivating Ligand for EphA1 and Inhibits ATF3-dependent Angiogenesis.

J. Masuda, R. Usui, and Y. Maru (2008)
J. Biol. Chem. 283, 13148-13155
 |  Abstract »  |  Full Text »  |  PDF »

Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?.

M. Lackmann and A. W. Boyd (2008)
Science Signaling 1, re2
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

A. S. Tsao, D. He, B. Saigal, S. Liu, J. J. Lee, S. Bakkannagari, N. G. Ordonez, W. K. Hong, I. Wistuba, and F. M. Johnson (2007)
Mol. Cancer Ther. 6, 1962-1972
 |  Abstract »  |  Full Text »  |  PDF »

Proangiogenic Role of ephrinB1/EphB1 in Basic Fibroblast Growth Factor-Induced Corneal Angiogenesis.

T. Kojima, J.-H. Chang, and D. T. Azar (2007)
Am. J. Pathol. 170, 764-773
 |  Abstract »  |  Full Text »  |  PDF »

Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer..

C. N. Landen Jr., C. Lu, L. Y. Han, K. T. Coffman, E. Bruckheimer, J. Halder, L. S. Mangala, W. M. Merritt, Y. G. Lin, C. Gao, et al. (2006)
J Natl Cancer Inst 98, 1558-1570
 |  Abstract »  |  Full Text »  |  PDF »

EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

O. Salvucci, M. de la Luz Sierra, J. A. Martina, P. J. McCormick, and G. Tosato (2006)
Blood 108, 2914-2922
 |  Abstract »  |  Full Text »  |  PDF »

The EphB4 Receptor-tyrosine Kinase Promotes the Migration of Melanoma Cells through Rho-mediated Actin Cytoskeleton Reorganization.

N.-Y. Yang, E. B. Pasquale, L. B. Owen, and I. M. Ethell (2006)
J. Biol. Chem. 281, 32574-32586
 |  Abstract »  |  Full Text »  |  PDF »

A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis.

Y. J. Jin, J. Wang, C. Qiao, T. K. Hei, P. W. Brandt-Rauf, and Y. Yin (2006)
Mol. Cancer Res. 4, 769-778
 |  Abstract »  |  Full Text »  |  PDF »

Essential Role of Vav Family Guanine Nucleotide Exchange Factors in EphA Receptor-Mediated Angiogenesis..

S. G. Hunter, G. Zhuang, D. Brantley-Sieders, W. Swat, C. W. Cowan, and J. Chen (2006)
Mol. Cell. Biol. 26, 4830-4842
 |  Abstract »  |  Full Text »  |  PDF »

EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme.

J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski (2005)
Mol. Cancer Res. 3, 541-551
 |  Abstract »  |  Full Text »  |  PDF »

Targeting Pancreatic Islets with Phage Display Assisted by Laser Pressure Catapult Microdissection.

V. J. Yao, M. G. Ozawa, M. Trepel, W. Arap, D. M. McDonald, and R. Pasqualini (2005)
Am. J. Pathol. 166, 625-636
 |  Abstract »  |  Full Text »  |  PDF »

EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma.

P. H. Thaker, M. Deavers, J. Celestino, A. Thornton, M. S. Fletcher, C. N. Landen, M. S. Kinch, P. A. Kiener, and A. K. Sood (2004)
Clin. Cancer Res. 10, 5145-5150
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Tumor Necrosis Factor-{alpha} (TNF{alpha}) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling.

T. Banno, A. Gazel, and M. Blumenberg (2004)
J. Biol. Chem. 279, 32633-32642
 |  Abstract »  |  Full Text »  |  PDF »

Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist.

P. Dobrzanski, K. Hunter, S. Jones-Bolin, H. Chang, C. Robinson, S. Pritchard, H. Zhao, and B. Ruggeri (2004)
Cancer Res. 64, 910-919
 |  Abstract »  |  Full Text »  |  PDF »

Ephrin-A1 Suppresses Th2 Cell Activation and Provides a Regulatory Link to Lung Epithelial Cells.

J. G. Wohlfahrt, C. Karagiannidis, S. Kunzmann, M. M. Epstein, W. Kempf, K. Blaser, and C. B. Schmidt-Weber (2004)
J. Immunol. 172, 843-850
 |  Abstract »  |  Full Text »  |  PDF »

Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.

B. de Saint-Vis, C. Bouchet, G. Gautier, J. Valladeau, C. Caux, and P. Garrone (2003)
Blood 102, 4431-4440
 |  Abstract »  |  Full Text »  |  PDF »

Ligand Binding Up-Regulates EphA2 Messenger RNA Through the Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Pathway.

R. L. Pratt and M. S. Kinch (2003)
Mol. Cancer Res. 1, 1070-1076
 |  Abstract »  |  Full Text »  |  PDF »

EphA3 Null Mutants Do Not Demonstrate Motor Axon Guidance Defects.

A. Vaidya, A. Pniak, G. Lemke, and A. Brown (2003)
Mol. Cell. Biol. 23, 8092-8098
 |  Abstract »  |  Full Text »  |  PDF »

`Eph'ective signaling: forward, reverse and crosstalk.

K. K. Murai and E. B. Pasquale (2003)
J. Cell Sci. 116, 2823-2832
 |  Abstract »  |  Full Text »  |  PDF »

EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway.

C. Deroanne, V. Vouret-Craviari, B. Wang, and J. Pouyssegur (2003)
J. Cell Sci. 116, 1367-1376
 |  Abstract »  |  Full Text »  |  PDF »

Differential Regulation of EphA2 in Normal and Malignant Cells.

J. Walker-Daniels, A. R. Hess, M. J.C. Hendrix, and M. S. Kinch (2003)
Am. J. Pathol. 162, 1037-1042
 |  Full Text »  |  PDF »

Human Endometrial Epithelial Cells Express Ephrin A1: Possible Interaction between Human Blastocysts and Endometrium via Eph-Ephrin System.

H. Fujiwara, S. Yoshioka, K. Tatsumi, K. Kosaka, Y. Satoh, Y. Nishioka, M. Egawa, T. Higuchi, and S. Fujii (2002)
J. Clin. Endocrinol. Metab. 87, 5801-5807
 |  Abstract »  |  Full Text »  |  PDF »

An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor.

M. Koolpe, M. Dail, and E. B. Pasquale (2002)
J. Biol. Chem. 277, 46974-46979
 |  Abstract »  |  Full Text »  |  PDF »

Differential Splicing Generates Tvl-1/RFXANK Isoforms with Different Functions.

S. Das, J.-H. Lin, J. Papamatheakis, Y. Sykulev, and P. N. Tsichlis (2002)
J. Biol. Chem. 277, 45172-45180
 |  Abstract »  |  Full Text »  |  PDF »

Blockade of EphA Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-Induced Angiogenesis.

N. Cheng, D. M. Brantley, H. Liu, Q. Lin, M. Enriquez, N. Gale, G. Yancopoulos, D. P. Cerretti, T. O. Daniel, and J. Chen (2002)
Mol. Cancer Res. 1, 2-11
 |  Abstract »  |  Full Text »  |  PDF »

c-Cbl-Dependent EphA2 Protein Degradation Is Induced by Ligand Binding.

J. Walker-Daniels, D. J. Riese II, and M. S. Kinch (2002)
Mol. Cancer Res. 1, 79-87
 |  Abstract »  |  Full Text »  |  PDF »

{alpha}5{beta}1 Integrin Activates an NF-{kappa}B-Dependent Program of Gene Expression Important for Angiogenesis and Inflammation.

S. Klein, A. R. de Fougerolles, P. Blaikie, L. Khan, A. Pepe, C. D. Green, V. Koteliansky, and F. G. Giancotti (2002)
Mol. Cell. Biol. 22, 5912-5922
 |  Abstract »  |  Full Text »  |  PDF »

Ephrin-B ligands play a dual role in the control of neural crest cell migration.

A. Santiago and C. A. Erickson (2002)
Development 129, 3621-3632
 |  Abstract »  |  Full Text »  |  PDF »

Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

N. Prevost, D. Woulfe, T. Tanaka, and L. F. Brass (2002)
PNAS 99, 9219-9224
 |  Abstract »  |  Full Text »  |  PDF »

Targeted Therapy against Human Lung Cancer in Nude Mice by High-Affinity Recombinant Antimesothelin Single-Chain Fv Immunotoxin.

D. Fan, S. Yano, H. Shinohara, C. Solorzano, M. Van Arsdall, C. D. Bucana, S. Pathak, E. Kruzel, R. S. Herbst, A. Onn, et al. (2002)
Mol. Cancer Ther. 1, 595-600
 |  Abstract »  |  Full Text »  |  PDF »

The Kinase-null EphB6 Receptor Undergoes Transphosphorylation in a Complex with EphB1.

A. Freywald, N. Sharfe, and C. M. Roifman (2002)
J. Biol. Chem. 277, 3823-3828
 |  Abstract »  |  Full Text »  |  PDF »

Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.

U. Huynh-Do, C. Vindis, H. Liu, D. P. Cerretti, J. T. McGrew, M. Enriquez, J. Chen, and T. O. Daniel (2002)
J. Cell Sci. 115, 3073-3081
 |  Abstract »  |  Full Text »  |  PDF »

Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes.

Y. Y. Li, Z. Mi, Y. Feng, C. F. McTiernan, R. Zhou, P. D. Robbins, S. C. Watkins, and A. M. Feldman (2001)
Am J Physiol Heart Circ Physiol 281, H2738-H2746
 |  Abstract »  |  Full Text »  |  PDF »

Downregulation of the Ras-Mitogen-Activated Protein Kinase Pathway by the EphB2 Receptor Tyrosine Kinase Is Required for Ephrin-Induced Neurite Retraction.

S. Elowe, S. J. Holland, S. Kulkarni, and T. Pawson (2001)
Mol. Cell. Biol. 21, 7429-7441
 |  Abstract »  |  Full Text »  |  PDF »

Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs.

H. S. Stadler, K. M. Higgins, and M. R. Capecchi (2001)
Development 128, 4177-4188
 |  Abstract »  |  Full Text »  |  PDF »

A role for the EphA family in the topographic targeting of vomeronasal axons.

B Knoll, K Zarbalis, W Wurst, and U Drescher (2001)
Development 128, 895-906
 |  Abstract »  |  PDF »

Gene Expression Profiling in an in Vitro Model of Angiogenesis.

J. Kahn, F. Mehraban, G. Ingle, X. Xin, J. E. Bryant, G. Vehar, J. Schoenfeld, C. J. Grimaldi, F. Peale, A. Draksharapu, et al. (2000)
Am. J. Pathol. 156, 1887-1900
 |  Abstract »  |  Full Text »  |  PDF »

Mesothelin Is Not Required for Normal Mouse Development or Reproduction.

T. K. Bera and I. Pastan (2000)
Mol. Cell. Biol. 20, 2902-2906
 |  Abstract »  |  Full Text »

Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation.

D.-Q. Guo, L.-W. Wu, J. D. Dunbar, O. N. Ozes, L. D. Mayo, K. M. Kessler, J. A. Gustin, M. R. Baerwald, E. A. Jaffe, R. S. Warren, et al. (2000)
J. Biol. Chem. 275, 11216-11221
 |  Abstract »  |  Full Text »  |  PDF »

Homeobox B3 Promotes Capillary Morphogenesis and Angiogenesis.

C. Myers, A. Charboneau, and N. Boudreau (2000)
J. Cell Biol. 148, 343-352
 |  Abstract »  |  Full Text »  |  PDF »

Fibroblast Growth Factor Receptor-Mediated Rescue of x-Ephrin B1-Induced Cell Dissociation in Xenopus Embryos.

L. D. Chong, E. K. Park, E. Latimer, R. Friesel, and I. O. Daar (2000)
Mol. Cell. Biol. 20, 724-734
 |  Abstract »  |  Full Text »

The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.

P. Helbling, D. Saulnier, and A. Brandli (2000)
Development 127, 269-278
 |  Abstract »  |  PDF »

A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes.

H.-C. Aasheim, E. Munthe, S. Funderud, E. B. Smeland, K. Beiske, and T. Logtenberg (2000)
Blood 95, 221-230
 |  Abstract »  |  Full Text »  |  PDF »

Monomeric Structure of the Human EphB2 Sterile alpha Motif Domain.

C. D. Thanos, S. Faham, K. E. Goodwill, D. Cascio, M. Phillips, and J. U. Bowie (1999)
J. Biol. Chem. 274, 37301-37306
 |  Abstract »  |  Full Text »  |  PDF »

Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.

K. S. Russell, D. F. Stern, P. J. Polverini, and J. R. Bender (1999)
Am J Physiol Heart Circ Physiol 277, H2205-H2211
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Rat Corneal Angiogenesis by 16-kDa Prolactin and by Endogenous Prolactin-like Molecules.

Z. Duenas, L. Torner, A. M. Corbacho, A. Ochoa, G. Gutierrez-Ospina, F. Lopez-Barrera, F. A. Barrios, P. Berger, Gonzalo Martinez de la Escalera, and C. Carmen (1999)
Invest. Ophthalmol. Vis. Sci. 40, 2498-2505
 |  Abstract »  |  Full Text »  |  PDF »

Cloning and Characterization of EphA3 (Hek) Gene Promoter: DNA Methylation Regulates Expression in Hematopoietic Tumor Cells.

M. Dottori, M. Down, A. Huttmann, D. R. Fitzpatrick, and A. W. Boyd (1999)
Blood 94, 2477-2486
 |  Abstract »  |  Full Text »  |  PDF »

E-Cadherin Regulates the Function of the EphA2 Receptor Tyrosine Kinase.

N. D. Zantek, M. Azimi, M. Fedor-Chaiken, B. Wang, R. Brackenbury, and M. S. Kinch (1999)
Cell Growth Differ. 10, 629-638
 |  Abstract »  |  Full Text »

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development.

N. W. Gale and G. D. Yancopoulos (1999)
Genes & Dev. 13, 1055-1066
 |  Full Text »

TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells.

C. N. Lynch, Y. C. Wang, J. K. Lund, Y.-W. Chen, J. A. Leal, and S. R. Wiley (1999)
J. Biol. Chem. 274, 8455-8459
 |  Abstract »  |  Full Text »  |  PDF »

The Carboxyl Terminus of B Class Ephrins Constitutes a PDZ Domain Binding Motif.

D. Lin, G. D. Gish, Z. Songyang, and T. Pawson (1999)
J. Biol. Chem. 274, 3726-3733
 |  Abstract »  |  Full Text »  |  PDF »

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

R. H. Adams, G. A. Wilkinson, C. Weiss, F. Diella, N. W. Gale, U. Deutsch, W. Risau, and R. Klein (1999)
Genes & Dev. 13, 295-306
 |  Abstract »  |  Full Text »

Eph receptors and ephrins: effectors of morphogenesis.

N Holder and R Klein (1999)
Development 126, 2033-2044
 |  Abstract »  |  PDF »

Tumor Necrosis Factor-alpha Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells.

E. Giraudo, L. Primo, E. Audero, H.-P. Gerber, P. Koolwijk, S. Soker, M. Klagsbrun, N. Ferrara, and F. Bussolino (1998)
J. Biol. Chem. 273, 22128-22135
 |  Abstract »  |  Full Text »  |  PDF »

Distinct Subdomains of the EphA3 Receptor Mediate Ligand Binding and Receptor Dimerization.

M. Lackmann, A. C. Oates, M. Dottori, F. M. Smith, C. Do, M. Power, L. Kravets, and A. W. Boyd (1998)
J. Biol. Chem. 273, 20228-20237
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis Is Coming of Age.

W. Risau (1998)
Circ. Res. 82, 926-928
 |  Full Text »  |  PDF »

Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses.

E. Stein, A. A. Lane, D. P. Cerretti, H. O. Schoecklmann, A. D. Schroff, R. L. Van Etten, and T. O. Daniel (1998)
Genes & Dev. 12, 667-678
 |  Abstract »  |  Full Text »

Nck Recruitment to Eph Receptor, EphB1/ELK, Couples Ligand Activation to c-Jun Kinase.

E. Stein, U. Huynh-Do, A. A. Lane, D. P. Cerretti, and T. O. Daniel (1998)
J. Biol. Chem. 273, 1303-1308
 |  Abstract »  |  Full Text »  |  PDF »

IL-1beta alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes.

Y. Y. Li, C. F. McTiernan, and A. M. Feldman (1998)
Am J Physiol Heart Circ Physiol 274, H331-H341
 |  Abstract »  |  Full Text »  |  PDF »

Regulated Expression of the Eph-Related Receptor Tyrosine Kinase Hek11 in Early Human B Lymphopoiesis.

H.-C. Aasheim, L. W.M.M. Terstappen, and T. Logtenberg (1997)
Blood 90, 3613-3622
 |  Abstract »  |  Full Text »  |  PDF »

Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function.

I. M. Rosenberg, M. Goke, M. Kanai, H.-C. Reinecker, and D. K. Podolsky (1997)
Am J Physiol Gastrointest Liver Physiol 273, G824-G832
 |  Abstract »  |  Full Text »  |  PDF »

Ligand for EPH-related Kinase (LERK) 7 Is the Preferred High Affinity Ligand for the HEK Receptor.

M. Lackmann, R. J. Mann, L. Kravets, F. M. Smith, T. A. Bucci, K. F. Maxwell, G. J. Howlett, J. E. Olsson, T. Vanden Bos, D. P. Cerretti, et al. (1997)
J. Biol. Chem. 272, 16521-16530
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Proliferation and Stimulation of Migration of Endothelial Cells by Secretoneurin In Vitro.

C. M. Kahler, R. Kirchmair, G. Kaufmann, S. T. Kahler, N. Reinisch, R. Fischer-Colbrie, R. Hogue-Angeletti, H. Winkler, and C. J. Wiedermann (1997)
Arterioscler Thromb Vasc Biol 17, 932-939
 |  Abstract »  |  Full Text »

Selective Expression of the Receptor Tyrosine Kinase, HTK, on Human Erythroid Progenitor Cells.

T. Inada, A. Iwama, S. Sakano, M. Ohno, K.-i. Sawada, and T. Suda (1997)
Blood 89, 2757-2765
 |  Abstract »  |  Full Text »  |  PDF »

Ligand Activation of ELK Receptor Tyrosine Kinase Promotes Its Association with Grb10 and Grb2 in Vascular Endothelial Cells.

E. Stein, D. P. Cerretti, and T. O. Daniel (1996)
J. Biol. Chem. 271, 23588-23593
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of a Novel Src-like Adapter Protein That Associates with the Eck Receptor Tyrosine Kinase.

A. Pandey, H. Duan, and V. M. Dixit (1995)
J. Biol. Chem. 270, 19201-19204
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor-alpha Induction of Endothelial Ephrin A1 Expression Is Mediated by a p38 MAPK- and SAPK/JNK-dependent but Nuclear Factor-kappa B-independent Mechanism.

N. Cheng and J. Chen (2001)
J. Biol. Chem. 276, 13771-13777
 |  Abstract »  |  Full Text »  |  PDF »

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.

X. X. Tang, H. Zhao, M. E. Robinson, B. Cohen, A. Cnaan, W. London, S. L. Cohn, N.-K. V. Cheung, G. M. Brodeur, A. E. Evans, et al. (2000)
PNAS 97, 10936-10941
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms of normal and tumor-derived angiogenesis.

M. Papetti and I. M. Herman (2002)
Am J Physiol Cell Physiol 282, C947-C970
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products